Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Amaranthus retroflexus whole is an allergenic extract derived from the entire plant of *Amaranthus retroflexus* (commonly known as redroot pigweed). It is primarily used in allergy testing to identify sensitivities to this specific plant allergen. The extract contains proteins and other components from the pollen and plant material that can provoke allergic reactions in sensitized individuals. There are no known pharmaceutical mechanisms of action beyond its use as a diagnostic tool for allergies. The product has been approved for use as an allergenic extract since 1986[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Amaranthus retroflexus whole.